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Desensitization and internalization of G-protein-cou-
pled receptors can reflect receptor phosphorylation-de-
pendent binding of -arrestin, which prevents G-protein
activation and targets receptors for internalization via
clathrin-coated vesicles. These can be pinched off by a
dynamin collar, and proteins controlling receptor inter-
nalization can also mediate mitogen-activated protein
kinase signaling. Gonadotropin-releasing hormone
(GnRH) stimulates internalization of its receptors via
clathrin-coated vesicles. Mammalian GnRH receptors
(GnRH-Rs) are unique in that they lack C-terminal tails
and do not rapidly desensitize, whereas non-mammalian
GnRH-R have C-terminal tails and, where investigated,
do rapidly desensitize and internalize. Using recombi-
nant adenovirus expressing human and Xenopus
GnRH-Rs we have explored the relationship between
receptor internalization and mitogen-activated protein
kinase signaling in HeLa cells with regulated tetracy-
cline-controlled expression of wild-type or a dominant
negative mutant (K44A) of dynamin. These receptors
were phospholipase C-coupled and had appropriate li-
gand affinity and specificity. K44A dynamin expression
did not alter human GnRH-R internalization but dra-
matically reduced internalization of Xenopus GnRH-R
(and epidermal growth factor (EGF) receptor). Blockade
of clathrin-mediated internalization (sucrose) abolished
internalization of all three receptors. Both GnRH-Rs
also mediated phosphorylation of ERK 2 and for both
receptors, this was inhibited by K44A dynamin. The
same was true for EGF- and protein kinase C-mediated
ERK 2 phosphorylation. ERK 2 phosphorylation was
also inhibited by a protein kinase C inhibitor but not
affected by an EGF receptor tyrosine kinase inhibitor.
We conclude that a) desensitizing and non-desensitizing
GnRH-Rs are targeted for clathrin-coated vesicle-medi-
ated internalization by functionally distinct mecha-
nisms, b) GnRH-R signaling to ERK 2 is dynamin-de-
pendent and c) this does not reflect a dependence on
dynamin-dependent GnRH-R internalization.
Sustained stimulation of most G-protein-coupled receptors
(GPCRs)1 causes their desensitization and internalization from
the cell surface. For many GPCRs this is mediated by G-protein
receptor kinases, which phosphorylate the receptor and pro-
mote the binding of -arrestin and a consequent reduction in
coupling of the receptor to its heterotrimeric G-proteins (1).
-arrestin also serves as an adapter, targeting the desensitized
receptor to clathrin-coated vesicles (CCVs) for internalization
(2). Once formed, the CCV is “pinched” off from the plasma
membrane by an oligomeric dynamin “collar”. This effect of
dynamin is dependent upon its intrinsic GTPase and can be
blocked by expression of GTPase-inactive (dominant negative)
mutants such as K44A dynamin (3). The internalized receptors
are then either recycled back to the surface membrane or
targeted to lysosomes for degradation so that agonist-induced
GPCR internalization can reinforce desensitization or underlie
resensitization.
Although this general scheme appears applicable to numer-
ous GPCRs, there are important exceptions. For example, in-
ternalization of the m2 muscarinic acetylcholine receptor and
the angiotensin 1A receptor is independent of both -arrestin
and dynamin (4–5) and internalization of endothelin 1A recep-
tors is apparently independent of both -arrestin and clathrin
(6–7). Thus, although these issues remain controversial (see
Refs. 8–11) for different GPCRs (and perhaps for different cell
types), the adapter protein targeting receptors for internaliza-
tion need not be -arrestin, the fission protein regulating in-
ternalization need not be dynamin, and the vesicle need not be
clathrin-coated.
Recent studies suggest that proteins mediating GPCR inter-
nalization may also mediate signaling. Thus -arrestin can
apparently recruit Src to agonist-occupied receptors, thereby
facilitating Ras-dependent extracellular signal-regulated ki-
nase (ERK) activation (12), so that the receptor, which is de-
sensitized in terms of G-protein-mediated signaling may actu-
ally be activated in terms of G-protein-independent signaling.
In addition, dominant negative forms of dynamin can inhibit
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mitogen-activated protein (MAP) kinase activation by GPCRs
(13, 14), an effect that could reflect a requirement of GPCR
internalization for MAP kinase activation (15) or a require-
ment for dynamin-dependent internalization of downstream
proteins such as MAP/ERK kinase (MEK) (16). Indeed, since
transactivation of the epidermal growth factor (EGF) receptors
(17–18) or release of EGF (19) can underlie GPCR-mediated
MAP kinase activation, the dynamin dependence of this effect
could also reflect the known dynamin dependence of tyrosine
kinase receptor-mediated MAP kinase activation (3).
The gonadotropin-releasing hormone receptor (GnRH-R) is a
phospholipase C-coupled GPCR that mediates neuroendocrine
control of gonadotropin secretion from pituitary gonadotropes
and thereby plays a central role in control of reproduction.
GnRH-Rs have a number of atypical structural characteristics
(20), notably the unique absence of C-terminal tails in type I
mammalian GnRH-Rs. In contrast, all cloned non-mammalian
GnRH-Rs possess such tails and, since the serine and threonine
residues that are phosphorylated by GRKs are often found
within the C-terminal tail, comparative studies have addressed
the functional relevance of these structures. These have
revealed that mammalian GnRH-Rs do not show rapid homo-
logous desensitization (21–22), whereas non-mammalian
GnRH-Rs do rapidly desensitize (23) and that, although mam-
malian GnRH-Rs undergo agonist-induced internalization via
CCVs, they are internalized much more slowly than non-
mammalian GnRH-Rs. Moreover, where investigated, non-
mammalian GnRH-Rs show agonist-induced phosphorylation
and -arrestin translocation and undergo -arrestin-dependent
internalization (24), whereas mammalian GnRH-Rs do not
(25). Using recombinant adenovirus expressing human and
type I Xenopus GnRH-Rs (Ad hGnRH-R and Ad XGnRH-R) we
have recently shown that these functional distinctions (desen-
sitization and internalization) are retained when GnRH-Rs are
expressed at physiological density and in gonadotrope lineage
cells (26). This supports the notion that GnRH-Rs have under-
gone a relatively recent period of accelerated molecular evolu-
tion that is functionally relevant and pertinent to the develop-
ment of mammalian reproductive strategies (27).
Here, we have explored the dynamin dependence of GnRH-R
internalization and MAP kinase signaling using recombinant
adenovirus to express human and Xenopus GnRH-Rs in HeLa
cells conditionally expressing wild-type or dominant negative
(K44A) dynamin under tetracycline control (tet-OFF). Both
receptors were positively coupled to PLC and MAP kinase
(ERK 2 phosphorylation) and, as anticipated, the non-mamma-
lian GnRH-Rs rapidly desensitized and internalized, whereas
these processes were slower or absent for the mammalian
GnRH-Rs. Both receptors were internalized via CCVs (as indi-
cated by sucrose dependence) but internalization of the
XGnRH-R was primarily dynamin-dependent, whereas that of
the hGnRH-R was not. MAP kinase activation was dynamin-
dependent for both receptors, was reduced by inhibition of
internalization or of PKC activity, and was not inhibited by an
EGF receptor, tyrophostin. Thus, desensitizing and non-desen-
sitizing GnRH-Rs undergo functionally distinct forms of inter-
nalization and show dynamin-dependent signaling that does
not reflect internalization of the GPCR or EGF receptor
transactivation.
EXPERIMENTAL PROCEDURES
Materials and Cell Culture—GnRH and chicken GnRH II (cGnRH-II)
were purchased from Peninsula Laboratories Europe Ltd. (Mersyside,
United Kingdom) or from Sigma. Buserelin and 125I-buserelin (2000
Ci/mmol) were provided by Prof. Sandow (Aventis Pharma GmbH,
Frankfurt, Germany). 125I-cGnRH-II (3400 Ci/mmol as determined by
self-displacement) was prepared using chloramine T and purified by
G25 Sephadex column chromatography.125I-EGF was purchased from
PerkinElmer Life Sciences. AG1478 was purchased from Calbiochem.
Culture media, sera, and plasticware were from Life Technologies, Inc.
or Falcon (Becton Dickinson, Oxford, UK). Lipofectin, LipofectAMINE,
and plus reagent were from Life Technologies, Inc., and FuGENE 6 was
from Roche Molecular Biochemicals. 2-[3H]inositol (14–16 Ci/mmol)
was from Amersham International (Little Chalfont, UK). Recombinant
adenovirus expressing the human GnRH-R (Ad hGnRH-R), the Xeno-
pus type I GnRH-R (Ad XGnRH-R) and EGFP (Ad EGFP) were gener-
ated as previously described (26), and CMV-EGFP was from CLON-
TECH. All other reagents were from standard commercial suppliers.
HeLa cells stably expressing either the wild-type (WT dynamin cells) or
the dominant negative GTPase-deficient mutant dynamin (K44A dy-
namin cells) (kindly provided by Dr. S. Schmidt, Scripps Institute, La
Jolla, CA) were cultured in serum-supplemented Dulbecco’s modified
Eagle’s medium with G418 (300 g/ml), puromycin (100 ng/ml), and
tetracycline (1 g/ml) as described (3). For experiments cells were
harvested by trypsinization, plated in Dulbecco’s modified Eagle’s me-
dium supplemented with 2% serum, and incubated for 2 days in flasks
or culture plates as described in figure legends. Cells were infected on
the second day, and where appropriate the tetracycline was removed.
After 8 h, the medium was replaced with fresh medium, with or without
tetracycline.
Accumulation of [3H]Inositol phosphates ([3H]IP)—[3H]IP accumula-
tion was used as a measure of PLC activity as described (28) using cells
labeled by pre-incubation with [3H]inositol and stimulated in the pres-
ence of LiCl. Cells were cultured in 24-well plates in 1 ml of media, and
2 Ci 2-[3H]inositol (14–16 Ci/mmol) was added to each well for the
final 16 h of incubation. After two washes with PSS (127 mM NaCl, 1.8
mM CaCl2, 5 mM KCl, 2 mM MgCl2, 0.5 mM NaH2PO4, 5 mM NaHCO3, 10
mM glucose, 0.1% (w/v), bovine serum albumin and 10 mM HEPES, pH
7.4), each well was stimulated for the period indicated in the figures
with 200 l of PSS containing 10 mM LiCl and the indicated concentra-
tion of buserelin, GnRH, or cGnRH-II. The stimulation was terminated
by adding 1 ml of water at 95 °C. The cells were lysed by freezing and
thawing and [3H]IP was separated from [3H]inositol using anion ex-
change chromatography in formate form Dowex-1 columns, and the
amount of 3H eluted in each fraction was determined by liquid scintil-
lation spectroscopy (28).
Radioligand Binding and Internalization Assays—GnRH-R expres-
sion was assessed and competition curves were constructed using whole
cell binding assays in which 50,000 cells were incubated in suspension
for 30 min at 21 °C in 100 l of PSS containing 1 mg/ml bacitracin with
1010 M radiolabel and 0 or 1010 to 105 M of the unlabeled compet-
itor peptide (26). Free and bound peptide were then separated by
centrifugation through oil. For the human GnRH-R, the radiolabel was
125I-buserelin and for Xenopus GnRH-R the radiolabel was 125I-cGnRH-
II. Similar assays were performed to quantify cell surface EGF recep-
tors. Approximately 50,000 cells were incubated in suspension for 3 h at
4 °C in 100 l PSS containing 1 mg/ml bacitracin with 0.2 nM 125I-
EGF and 0 or 106 M of unlabeled EGF. Free and bound peptides were
then separated by centrifugation through oil.
Internalization of EGF receptors was quantified in a modified whole
cell binding assay in which 250,000 cells were grown in 6-well plates.
Cells were washed in PSS and then incubated at 37 °C in 1 ml of PSS
containing 107 M EGF. After the required incubation period (2–45
min) the cells were rapidly rinsed in ice-cold PSS (two times) and then
incubated for 5 min in ice-cold 150 mM NaCl,50 mM acetic acid (pH 3)
before scraping, pelleting, and resuspending in PSS. Internalization of
GnRH-R was quantified in a modified whole cell binding assay in which
50,000 cells (grown in 24-well plates) were washed in PSS and then
incubated at 37 °C in 200 l of PSS containing 1010 M radiolabel and
0 (total binding) or 106 M (nonspecific binding) of buserelin or cGnRH-
II. After the required incubation period (5–30 min) the cells were
rapidly rinsed in ice-cold PSS (two times) and then incubated for 2 min
either in ice-cold PSS or in ice-cold 150 mM NaCl,50 mM acetic acid (pH
3). The cells were then washed three more times in ice-cold PSS and
solubilized in 0.5 ml of 0.2 M NaOH with 1% SDS. Radiolabel in the
solubilized cells was determined by  counting, and specific cell-associ-
ated radioactivity was determined by subtraction of nonspecific from
the total. Total specific binding is defined as the specific binding in cells
receiving no acid wash, whereas acid-resistant (internalized)-specific
binding is defined as that seen in the acid washed cells. An internal-
ization index was calculated by expressing acid-resistant-specific bind-
ing as a percentage of total cell-associated-specific binding.
Fluid phase endocytosis was determined by measuring uptake of
horseradish peroxidase as described (29). Briefly, cells were cultured at
250,000 cells/well in 6-well plates and infected with Ad hGnRH-R or Ad
XGnRH-R (m.o.i. 100) as above. They were then incubated for 60 min at


























37 °C in 0.5 ml of Dulbecco’s modified Eagle’s medium containing 5
mg/ml horseradish peroxidase (Sigma) and 0 or 107 M GnRH or
cGnRH-II. Uptake was terminated by repeated washing in ice-cold
phosphate-buffered saline prior to cell lysis with 0.1% Triton X-100 in
phosphate-buffered saline. Horseradish peroxidase activity was then
determined using 3,3-diaminobenzidine as a substrate followed by col-
orimetric measurement at 450 nm.
Dynamic Video Imaging of Cystolic Ca2—Cytosolic Ca2 concentra-
tion was measured by dynamic video imaging using MagiCal hardware
and Tardis software with a Nikon Diaphot microscope with 40 quartz
oil immersion objective (30). Cells were cultured on glass coverslips in
flat-bottomed 12-well plates and were washed and then incubated for
30 min at 37 °C with PSS containing 2 M fura-2 acetoxmethyl ester
(fura-2/AM). Immediately before imaging the coverslip was dipped into
PSS, blotted, and mounted on a greased incubation chamber. The cells
were kept immersed in media constantly. Media changes were carried
out by pipetting 4 ml of solution into the chamber, while an aspiration
tube removed excess liquid and maintained a constant volume of
around 400 l. The samples in the chamber were illuminated alter-
nately at 340 and 380 nm, and the ratio of the light emitted at 510 nm
was measured, averaging 16 video frames to minimize the pixel to pixel
standard error. This ratio was proportional to the intracellular ionized
Ca2. For calibration, a dissociation constant of 225 nM for fura-2 and
Ca2 at 37 °C was used, and minimal and maximal fluorescence at 340
and 380 nm were determined in cells loaded with dye and made per-
meable to extracellular Ca2 with 10 M ionomycin in solutions con-
taining either 10 mM Ca2 or 10 mM EGTA.
Measurement of ERK 2 Activation by Western Blotting—Activation of
ERK 2 was measured by Western blotting according to standard tech-
niques. Briefly HeLa cells were plated in 6-well plates at 250,000
cells/well, infected with either Ad XGnRH-R or Ad hGnRH-R at an
m.o.i. of 50–100, and left to express for 24 h. Following treatment, the
cells were washed twice in ice-cold phosphate-buffered saline before
being lysed on ice for 10 min in 400 l of extraction buffer (10 mM Tris,
pH 7.6, 5 mM EDTA, 1 mM EGTA, 50 mM NaCl, 30 mM sodium pyro-
phosphate, 50 mM NaF, 1 mM dithiothreitol, 100 M sodium orthovana-
date, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml
antipain, 2 g/ml leupeptin, 2 g/ml pepstatin). Samples were then
centrifuged (13,000  g, 4 °C, 10 min) to clear the supernatant before 40
l of aliquots were boiled with 40 l of sample buffer. Proteins were
separated by SDS-polyacrylamide gel electrophoresis (8% gel), trans-
ferred to polyvinylidene difluoride membrane and blocked with 5%
skimmed milk/Tris-buffered saline Tween. ERK 2 was detected using
monoclonal anti-ERK 2 (Santa Cruz) and visualized using enhanced
chemiluminescence (ECL, Amersham Pharmacia Biotech). The unphos-
phorylated and phosphorylated forms of ERK 2 were distinguished by
retardation of the latter in SDS-polyacrylamide gel electrophoresis.
Both bands were scanned and quantified by densitometry (Quantity 1
Software, Bio-Rad), and the phosphorylated ERK 2 was expressed as a
percentage of total ERK 2 (both bands).
Statistical Analysis and Data Presentation—The figures show the
mean  S.E. of data pooled from “n ” independent experiments (raw
data or data normalized as described in the figure legends). Data are
typically reported in text as mean  S.E., and statistical analysis was
by analysis of variance and Student’s t test, accepting p  0.05 as
statistically significant. EC50 values were estimated by non-linear re-
gression using “Graphpad Prism” (Graphpad Prism, San Diego, CA).
RESULTS
To explore the dynamin dependence of GnRH-R desensitiza-
tion, internalization, and signaling, we sought to express hu-
man and Xenopus GnRH-Rs in HeLa cells expressing wild-type
or K44A dynamin under control of the tetracycline-response
element and a tetracycline-controlled transactivator. However,
transfection efficiencies were found to be extremely low in
these cells when conventional strategies (CaPO4, Lipofectin,
LipofectAMINE Plus, and FuGENE) were used. Using flow
cytometry to assess protein expression after transfection with a
CMV-EGFP plasmid we estimated that 20% of cells were
transfected. In contrast transfection efficiencies approaching
100% were obtained using recombinant EGFP-expressing ade-
novirus (not shown). We therefore made use of previously gen-
erated recombinant adenovirus expressing human and Xeno-
pus laevis type I GnRH-Rs (Ad hGnRH-R and Ad XGnRH-R,
respectively).
Since these receptors have not (to our knowledge) been pre-
viously expressed in HeLa cells, it was necessary to first per-
form a basic pharmacological characterization. This was un-
dertaken using WT dynamin cells maintained in medium with
tetracycline (conditions not permissive for transgene expres-
sion). To determine the relationship between viral titer and
receptor expression we constructed competition binding curves
using 125I-buserelin and varied amounts of unlabeled busere-
lin. No specific binding was seen in untransfected cells, but
infection with Ad hGnRH-R with increasing titer (from m.o.i. of
3–100) increased 125I-buserelin binding, and this was inhibited
in a concentration-dependent manner by unlabeled buserelin.
Fitting this data to a single site competition model revealed no
dependence of Kd value on viral titer, so Bmax values were
estimated by refitting the data with the Kd fixed at the mean
value of 2.4 nM (2.4 nM  0.3 nM, n  3). This revealed receptor
densities of 3000, 14,600, 25,500, and 46,500 sites/cell at m.o.i.
values of 3, 10, 30, and 100, respectively (Fig. 1). Similar
experiments with 125I-cGnRH-II and unlabeled cGnRH-II in
cells infected with Ad XGnRH-R again revealed high affinity
binding sites with no relationship between Ad titer and Kd. The
data was therefore fitted through the mean Kd value of 3.1 nM
(3.1 nM  0.9 nM, n  3). This revealed receptor densities of
6600, 17,000, 49,000, and 215,000 sites/cell at m.o.i. values of 3,
10, 30, and 100, respectively (data not shown).
To establish whether these binding sites were functional
GnRH-Rs, GnRH-stimulated [3H]IP accumulation was meas-
ured in cells infected with Ad hGnRH-R at varied titer. No
stimulation was seen in untransfected cells or in cells infected
at low viral titer (m.o.i. of 3), but GnRH did cause a clear dose-
and titer-dependent stimulation of [3H]IP accumulation at
higher titers. At m.o.i. values of 3, 10, 30, and 100, 4.7% 
2.0%, 3.8%  0.9%, 11.8%  3.3, and 31.7%  7.5%, respec-
tively, of total [3H]inositol was found in the [3H]IP fraction
after 30 min stimulation with a maximally effective concentra-
tion of GnRH (Fig. 1). A similar dose- and titer-dependent
stimulation of [3H]IP accumulation was seen in HeLa cells
infected with Ad XGnRH-R (not shown). When these cells were
stimulated for 30 min with 106 M cGnRH-II after infection at
m.o.i. values of 3, 10, 30, and 100, cGnRH increased the pro-
portion of [3H]inositol recovered in the [3H]IP fraction to 3.6%
 0.2%, 5.9%  0.9%, 13.1%  4.1, and 32.3%  1.7%, respec-
tively. Interestingly, the maximal observed [3H]IP responses
were comparable (32%) for both receptors despite the fact
that 4–5 times more XGnRH-R were expressed at the m.o.i. of
100. This distinction is similar to that observed with the same
GnRH-R expressed in T4 pituitary cells and may reflect dif-
ferential desensitization during the course of the [3H]IP accu-
mulation assay (26).
Since activation of PLC mediates elevation of [Ca2]i by
GnRH in pituitary cells, we also assessed possible effects of
GnRH on Ca2 in Ad hGnRH-R-infected HeLa cells. As shown
(Fig. 1), GnRH did not increase [Ca2]i in control fura-2-loaded
HeLa cells but caused a sustained and titer-dependent increase
after infection at m.o.i. values of 3–100. Since these data were
acquired by video imaging it was also possible to determine the
proportion of cells responding to GnRH. This revealed that the
vast majority of cells (80%) responded to GnRH at relatively
low titer (m.o.i. values of 10–30), and that increasing viral titer
above an m.o.i. of 10 increased the amplitude of the responses
without increasing the proportion of cells responding. These
data (not shown) are very similar to those previously obtained
when Ad GnRH-R were used to infect pituitary cells (26).
To determine the ligand specificity of GnRH-Rs expressed in
these cells competition binding assays were performed using
unlabeled GnRH, buserelin, and cGnRH-II and 125I-buserelin


























or 125I-cGnRH-II in cells infected with Ad hGnRH-R or Ad
XGnRH-R, respectively (both at an m.o.i. of 100). The rank
order of potency for competition at the hGnRH-R was
buserelinGnRHcGnRH-II, whereas that at the XGnRH-R
was cGnRH-IIbuserelinGnRH (not shown). Identical
rank orders of potency were seen when HeLa cells infected with
Ad hGnRH-R or Ad XGnRH-R were used to construct dose-
response curves for [3H]IP accumulation (not shown).
We next investigated desensitization of these receptors. To
do so WT dynamin cells were infected with either Ad hGnRH-R
or Ad XGnRH-R (at m.o.i. values of 100) and then used in
time-course experiments in which [3H]IP accumulation was
measured. As shown (Fig. 2, upper panel) both receptors medi-
ated comparable initial rates of [3H]IP accumulation, but this
initial rate was not maintained beyond 2 min for XGnRH-Rs
stimulated by cGnRH-II. As an index of desensitization, the
rate of accumulation between 2–5 min was only 9%  3% of the
initial rate (0–2 min) for the XGnRH-R but was as high as 73%
 15% for the hGnRH-R.
FIG. 1. Titer dependence of receptor expression and signaling
in WT dynamin cells infected with Ad hGnRH-R. Upper panel, WT
dynamin cells were cultured in 60-mm Petri dishes in the presence of
tetracycline and infected with Ad hGnRH-R at m.o.i. values of 100 (E),
30 (●), 10 (‚), 3 ( Œ), and 0 (ƒ) and then cultured for a further 24 h
before being scraped from the culture vessels and used for suspension
binding assays using 0.25 nM 125I-buserelin and the indicated concen-
tration of unlabeled buserelin. Pooled Kd values were 2.4  0.3 nM (n 
3) for buserelin binding to the hGnRH-R. The values shown are the
mean  S.E. normalized as a percentage of the binding seen with no
competitor at an m.o.i. of 100. Center panel, WT dynamin cells cultured
in 24 wells in the presence of tetracycline were infected with Ad
hGnRH-R at m.o.i. values of 100 (E), 30 (●), 10 (‚), and 3 (Œ) and then
cultured for a further 24 h. 2 Ci of [3H]inositol was added to the
medium for the final 16 h of culture after which the cells were washed
and stimulated for 30 min with the indicated concentration of GnRH in
the presence of 10 mM LiCl. Data shown are the mean  S.E. of three
experiments, each having duplicate determinations. The data was nor-
malized by expressing 3H eluted in the IP fraction as a percentage of
that of free [3H]inositol and IP fractions (e.g. fraction 3 as a % of fraction
1  fraction 3). This provides an internal control for cell number and
labeling efficiency and thereby facilitates pooling of data from repeated
experiments. Lower panel, WT dynamin cells were infected with Ad
hGnRH-R at m.o.i. values of 0 (E), 3 (●), 10 (‚), 30 (Œ), and 100 (ƒ) and
then cultured for 18 h before being loaded with fura-2 and used for Ca2
imaging. During imaging the cells were stimulated with 107 M GnRH
as indicated. Each trace shows mean  S.E. from three separate imag-
ing experiments (n  3), each using 10–50 cells.
FIG. 2. Time course of [3H]IP accumulation and internaliza-
tion in WT dynamin cells infected with Ad hGnRH-R or Ad
XGnRH-R. Upper panel: WT dynamin cells cultured in 24 wells in the
presence of tetracycline were infected with Ad hGnRH-R (open symbols)
or Ad XGnRH-R (closed symbols) at m.o.i. values of 50–100 and then
cultured for a further 24 h. 2 Ci of [3H]inositol was added to the
medium for the final 16 h of culture after which the cells were washed
and stimulated for the indicated time with the 107 M GnRH
(hGnRH-R) or cGnRH-II (XGnRH-R), in the presence of 10 mM LiCl.
The data are mean  S.E. (n  4–7) of pooled data normalized as a
percentage of the [3H]IP accumulation at 2 min. Lower panel, WT
dynamin cells cultured in 24 wells in the presence of tetracycline were
infected with Ad hGnRH-R (open symbols) or Ad XGnRH-R (closed
symbols) at m.o.i. values of 50–100 and then cultured for a further 24 h.
Cells were washed and incubated for the indicated period of time in PSS
containing 0.25 nM 125I-buserelin (hGnRH-R) or 0.125 nM 125I-cGnRH-
II (XGnRH-R) with 0 or 106 M buserelin or cGnRH-II (nonspecific
binding). The binding was terminated by transfer to ice-cold PSS and
washing before solubilization of the cells in 0.2 M NaOH and 1% SDS. In
a parallel experiment, cells were treated exactly as described above
except that, after binding, the cells were incubated in acid medium to
remove radioligand binding from cell surface receptors. Data shown are
mean  S.E. (n  3) of specific binding (nonspecific binding subtracted)
pooled from repeated experiments, each having triplicate observations
that were expressed as a percentage of total specific binding (acid-labile
plus acid-resistant) at 30 min.


























To monitor receptor internalization, WT dynamin cells were
infected with either Ad hGnRH-R or Ad XGnRH-R (m.o.i. 100)
and used in time-course experiments in which both total spe-
cific binding and acid resistant-specific binding were measured.
Both ligands associated rapidly with their receptors with half-
maximal binding at 5–10 min (not shown). However, the acid-
resistant fraction of specific binding was greater in cells ex-
pressing XGnRH-Rs than hGnRH-Rs at all time points (Fig. 2,
lower panel). To test whether these receptors stimulate fluid
phase endocytosis, uptake of horseradish peroxidase was quan-
tified in cells stimulated for 60 min with 0 or 107 M GnRH.
Enzyme uptake was temperature-dependent (increased 2–3-
fold by increasing from 4 °C to 37 °C) but was not measurably
influenced by GnRH in Ad hGnRH-R-infected cells (93  8% of
control, n  4) or by cGnRH-II in Ad cGnRH-II-infected cells
(109  9% of control, n  4).
We next determined the effectiveness of the K44A dynamin
blockade of internalization using the endogenous EGF recep-
tors as controls. Pretreatment with EGF caused a time-depend-
ent loss of cell surface EGF receptors (as judged by subsequent
whole cell binding assays at 4 °C). In K44A dynamin cells
cultured with tetracycline, surface binding was reduced to
26.8%  10.4%, 16.2%  1.3%, 9.1%  2.9%, and 8.1%  1.1%
of control after 5, 15, 30, and 45 min, respectively (not shown).
In contrast, no significant loss was seen in cells cultured in the
absence of tetracycline (conditions permissive for expression of
the dominant negative transgene). The specificity of this effect
was established by control experiments in which EGF pretreat-
ment caused a clear loss of cell surface receptors in WT dy-
namin HeLa cells, irrespective of the absence or presence of
tetracycline in the culture medium.
The dynamin dependence of GnRH-R internalization was
next investigated by infecting K44A dynamin cells with Ad
hGnRH-R or Ad XGnRH-R, culturing these cells in the pres-
ence or absence of tetracycline, and then quantifying receptor
internalization at 37 °C as above. As shown (Fig. 3, upper
panel), 125I-buserelin internalization (hGnRH-R-mediated)
proceeded relatively slowly in control cells (cultured with tet-
racycline) to a maximum at 120 min with a half-time of 30–60
min. Omission of tetracycline from the culture medium (per-
missive for K44A dynamin expression) did not measurably
influence this time-course. 125I-cGnRH-II internalization (via
XGnRH-R) was relatively rapid in control cells cultured with
tetracycline (no measurable increase after 30 min and a half-
time of 10 min) and was clearly reduced in cells cultured
without tetracycline (Fig. 3, lower panel). In control experi-
ments (not shown), tetracycline had no direct effect on radioli-
gand binding to either of these GnRH-R, and omission of tet-
racycline from the culture medium did not measurably
influence internalization of either receptor in cells expressing
wild-type dynamin (under tet-off control).
To determine whether differences in receptor number under-
lie the observed differences in dynamin dependence, internal-
ization was assessed in cells infected with Ad hGnRH-R or Ad
XGnRH-R at varied m.o.i. (from 3–100) and cultured with and
without tetracycline. Fig. 4 shows the relationship between
total specific binding (an index of receptor number) and acid-
resistant binding (an index of receptor internalization) using
data accumulated over four separate experiments. As expected,
XGnRH-R internalization was greater than that for the
hGnRH-R (72  4% (n  28) and 23  2% (n  25), respectively,
data pooled irrespective of m.o.i.), and omission of tetracycline
reduced the rate of XGnRH-R internalization (to 17  2%, n 
30, p  0.05) without altering that of the hGnRH-R (p  0.1).
Linear regression revealed that the rate of internalization of
the XGnRH-R reduced as receptor number increased (gradient
different from 0 at p  0.05), but most importantly, the dy-
namin dependence of XGnRH-R internalization was main-
tained at a range of receptor densities encompassing those at
which the hGnRH-R showed no dynamin dependence (Fig. 4).
We next addressed the dependence of GnRH-R internaliza-
tion on CCVs using hypertonic sucrose (Fig. 5), which prevents
the formation of clathrin lattices on coated pits and thereby
prevents CCV-mediated receptor internalization (31). Using
15-min incubations, 72%  8% of 125I-EGF binding was acid-
resistant under control conditions, but this was reduced to 30%
 5% (p  0.05) by tetracycline omission (K44A expression).
Similarly 51%  7% of 125I-cGnRH-II binding to Ad XGnRH-
R-infected cells was acid-resistant under control conditions, but
this was reduced to 19%  4% (p  0.05) by allowing K44A
expression. In contrast, only 22%  4% of 125I-buserelin bind-
ing was acid-resistant in control Ad hGnRH-R-infected cells,
and this was not measurably altered by allowing K44A expres-
sion. Hypertonic sucrose (0.4 M) reduced the acid-resistant
binding of all three ligands, to less than 5% without altering
total specific binding (not shown), irrespective of the presence
or absence of tetracycline (not shown). These data suggest that
CCVs mediate dynamin-dependent and -independent internal-
ization of GnRH-R.
Since GnRH is known to activate MAP kinase signaling in
pituitary cells and GPCR-mediated MAP kinase activation can
be dynamin-dependent, we next explored the possible effects on
ERK 2 phosphorylation in Ad GnRH-R-infected K44A dynamin
FIG. 3. Dynamin dependence of XGnRH-R and hGnRH-R inter-
nalization in K44A dynamin cells. K44A dynamin cells cultured in
24 wells in the presence of tetracycline were infected with Ad hGnRH-R
(upper panel) or Ad XGnRH-R (lower panel) at m.o.i. values of 50–100.
HeLa (K44A) cells were then cultured with (open symbols) or without
(closed symbols) tetracycline for 8 h to allow infection before the me-
dium was changed to fresh containing no Ad with or without tetracy-
cline to allow expression of the mutant dynamin and then cultured for
a further 16 h. Cells were washed and incubated for the indicated period
of time in PSS containing 0.25 nM 125I-buserelin (hGnRH-R) or 0.125
nM 125I-cGnRH-II (XGnRH-R) with 0 or 106 M buserelin or cGnRH-II
(nonspecific binding). Transfer to ice-cold PSS and washing in PSS
(total binding) or acid (internal binding) terminated the binding. The
data shown are mean  S.E. (n  3) of acid-resistant binding expressed
as a percentage of total specific binding pooled from repeated experi-
ments, each having duplicate observations.


























cells cultured with and without tetracycline. As shown (Fig. 6),
GnRH and cGnRH-II both caused pronounced activation of
ERK 2 phosphorylation in control cells (expressing hGnRH-Rs
and XGnRH-Rs, respectively) with comparable time-courses
(maxima achieved at 10 min. with subsequent reduction to
near basal levels at 60 min). Stimulation of ERK 2 phospho-
rylation was also seen in cells cultured without tetracycline,
but for both receptors the response was significantly reduced
(area under the curve 75.9%  5.8 and 73.6%  7.4% (p  0.05)
of control for XGnRH-Rs and hGnRH-Rs, respectively). Thus,
although the internalization of the hGnRH-R is apparently not
dependent upon dynamin in HeLa cells, its effect on ERK 2
phosphorylation clearly is.
To explore the relationship between receptor internalization
and signaling, we blocked internalization with sucrose and
tested for possible inhibition of GnRH-R-mediated ERK 2 acti-
vation. However, these experiments were complicated by the
fact that sucrose itself activated ERK 2 (not shown) and we
therefore sought an alternative means of blocking internaliza-
tion. As shown (Fig. 7), the lectin, concanavalin A, had no
measurable effect on XGnRH-R-mediated ERK 2 phosphoryla-
tion in control cells (not expressing K44A dynamin), despite the
fact that it reduced 125I-cGnRH-II internalization by 70%
(from 68  4% (n  4) to 17  1% (n  5), p  0.05). Similar
results (inhibition of internalization but not of signaling) were
obtained with Ad hGnRH-R infected cells (not shown).
To further explore the mechanism of ERK 2 activation in
these cells, effects of PKC activation and inhibition were deter-
mined. As shown (Fig. 8), the PKC activator PMA (like GnRH
and cGnRH-II) increased ERK 2 phosphorylation in control
cells (not expressing K44A dynamin). PMA had no significant
effect in the presence of the PKC inhibitor bisindolylmaleimide
1 (demonstrating the efficiency of the blocker), and the re-
sponses to activation of hGnRH-Rs and XGnRH-Rs were both
inhibited by the inhibitor (to 50%  8 and 40%  8% (p  0.05)
of maximum, respectively), demonstrating a mediatory role for
PKC. Expression of K44A dynamin inhibited hGnRH-R- and
XGnRH-R-mediated ERK 2 phosphorylation as expected (to
26%  10 and 45%  7% (p  0.05) of maximum stimulation,
respectively) and also inhibited PMA-stimulated ERK 2 phos-
phorylation (to 59%  3%, p  0.05), demonstrating that such
inhibition is not GnRH-R-specific. When K44A dynamin was
expressed, the dynamin-independent component of PMA-stim-
ulated ERK 2 activation was blocked by bisindolylmaleimide 1
(again, demonstrating dependence on PKC activation), but we
were unable to detect any such inhibition for responses to
GnRH or cGnRH-II, implying that the dynamin-independent
signaling of these receptors to ERK 2 is not PKC-mediated.
In a final series of experiments the effects of GnRH, cGnRH-
II, and EGF were assessed in the presence and absence of the
EGF receptor tyrosine kinase inhibitor AG1478. As shown (Fig.
9) EGF, GnRH, and cGnRH-II caused comparable phosphoryl-
ation of ERK 2 and were all sensitive to inhibition by expres-
sion of K44A dynamin (not shown). In contrast, 1000 nM
AG1478 prevented EGF-stimulated ERK 2 phosphorylation
without measurably altering the ERK 2 phosphorylation me-
diated by activation of either GnRH-R.
DISCUSSION
The GnRH receptor family has undergone a period of rapidly
accelerated molecular evolution in which the C-terminal tails,
present on all known non-mammalian GnRH-R, have been lost
with the advent of mammalian type I GnRH-R. This provides a
unique opportunity to study the functional relevance of these
features with normal (non-mutated) receptors. Such studies
FIG. 4. Density and dynamin dependence of XGnRH-R and
hGnRH-R internalization in K44A dynamin cells. K44A dynamin
cells cultured in 24 wells in the presence of tetracycline were infected
with Ad hGnRH-R (upper panel) or Ad XGnRH-R (lower panel) at m.o.i.
values of 3–100. HeLa (K44A) cells were then cultured with (open
symbols) or without (closed symbols) tetracycline for 8 h to allow infec-
tion before the medium was changed to fresh containing no Ad with or
without tetracycline to allow expression of the mutant dynamin and
then cultured for a further 16 h. They were then used in whole cells
receptor internalization assays as above (Fig. 3 legend). The figures
show total specific binding (an index of receptor number, x axis) plotted
against the proportion of binding that was acid-resistant (% internal-
ized, y axis). The data are pooled from multiple experiments, with each
dot representing a single determination of each parameter from a single
internally controlled experiment with triplicate replicates. Linear re-
gression revealed a significant negative correlation of log transformed
binding data and internalization data for the XGnRH-R with and with-
out tetracycline (slope different from 0 at p  0.05 in both cases) but not
for the hGnRH-R (p  0.1 in both cases).
FIG. 5. Effect of sucrose on the internalization of XGnRH-R
and hGnRH-R in K44A dynamin cells. K44A dynamin cells cultured
in 24 wells in the presence of tetracycline were infected with Ad
hGnRH-R (open bars) or Ad XGnRH-R (black bars) at m.o.i. values of
50–100 or left uninfected for EGF-R (gray). K44A dynamin cells were
then cultured with (control cells) or without (K44A mutant) tetracycline
for 8 h to allow infection before the medium was changed to fresh
containing no Ad with or without tetracycline and then cultured for a
further 16 h. Cells were washed and pretreated with PSS with or
without 0.4 M sucrose for 30 min before radioligand binding and inter-
nalization for 15 min. Transfer to ice-cold PSS and washing in PSS
(total binding) or acid (internal binding) terminated the binding. The
data shown are mean  S.E. (n  3–12) of acid-resistant binding
expressed as a percentage of total specific binding pooled from repeated
experiments, each having triplicate observations (* p  0.05 compared
with control, ** p  0.05 compared with K44A dynamin inhibited
response).


























have revealed that mammalian GnRH-R do not rapidly desen-
sitize whereas the two non-mammalian GnRH-R investigated
to date (catfish (23) and Xenopus GnRH-R (26)) do show rapid
homologous desensitization. Similarly, mammalian GnRH-Rs
undergo agonist-induced internalization, but at much lower
rates than non-mammalian GnRH-R (24, 26, 27). The resist-
FIG. 6. Effect of dynamin on the time course of ERK 2 activa-
tion in K44A dynamin cells infected with Ad hGnRH-R or Ad
XGnRH-R. Phosphorylation of ERK 2 was assessed by Western blot-
ting to detect and distinguish unphosphorylated and phosphorylated
ERK 2 by the retarded mobility of the latter in SDS-polyacrylamide gel
electrophoresis (inset). HeLa (K44A) cells were infected with Ad
hGnRH-R (upper panel) or Ad XGnRH-R (lower panel) at m.o.i. values
of 50–100 before being cultured with (open symbols) or without (closed
symbols) tetracycline. Cells were then stimulated with 107 M GnRH
(hGnRH-R) or cGnRH-II (XGnRH-R) for the indicated period of time.
The figure shows mean  S.E. (n  4) calculated after expressing the
phosphorylated ERK 2 as a percentage of total ERK 2 (both determined
by densitometry).
FIG. 7. Influence of concanavalin A on XGnRH-R-mediated
ERK 2 activation. ERK 2 phosphorylation was determined and quan-
tified as described above in K44A HeLa cells infected with Ad XGnRH-R
at an m.o.i. of 100. The cells were pretreated with 0 or 0.25 mg/ml
concanavalin A (Con A) for 30 min prior to stimulation for 15 min with
0 or 107 M cGnRH-II as indicated. The figure shows mean  S.E. (n 
3) calculated after expressing the phosphorylated ERK 2 as a percent-
age of total ERK 2 (both determined by densitometry). ERK 2 phospho-
rylation was not measurably influenced (p  0.1) by concanavalin A in
the presence or absence of cGnRH-II. Similar data were obtained in
cells infected with Ad hGnRH-R and stimulated with 0 or 107 M GnRH
(not shown).
FIG. 8. PKC-dependence of GnRH-R-mediated activation of
ERK 2 in K44A dynamin cells infected with Ad hGnRH-R or Ad
XGnRH-R. K44A dynamin cells were infected with Ad hGnRH-R or Ad
XGnRH-R at m.o.i. values of 50–100 before being cultured with or
without tetracycline. Cells were then pretreated with PSS with or
without 1 M bisindolylmaleimide 1 for 30 min before being stimulated
with PSS containing 30 nM PMA (top panel), 100 nM GnRH (hGnRH-R,
middle panel) or cGnRH-II (XGnRH-R, bottom panel) for 10 min before
extraction. Data is expressed as a percentage of maximal stimulation
determined by the proportion of ERK 2 that is in the phosphorylated
form from pooled observations (n  3), as determined by densitometry
measurement. The PMA control is pooled from both hGnRH-R- and
XGnRH-R-infected cells (n  6) (* p  0.05 compared with maximal
stimulation (no inhibitor), ** p  0.05 compared with both maximal
stimulation and dynamin blocked stimulation).


























ance of mammalian GnRH-R to desensitization and internal-
ization has been attributed to the lack of required C-terminal
tail phosphorylation sites since catfish GnRH-R do undergo
agonist-induced phosphorylation and bind -arrestin (causing
it to translocate to the plasma membrane), whereas mamma-
lian GnRH-R do not (32). Similarly, we have found that
XGnRH-R mediate translocation of -arrestin-GFP to plasma
membranes, whereas hGnRH-R do not (not shown). Moreover,
internalization of catfish GnRH-R is -arrestin-dependent (24),
whereas internalization of the human GnRH-R is not (25).
Thus non-mammalian GnRH-Rs appear to follow the scheme
outlined above for -arrestin-mediated desensitization and in-
ternalization (and possible -arrestin-mediated signaling), but
this is not the case for the mammalian GnRH-Rs investigated
to date (20, 22).
Here we have explored the dynamin dependence of desensi-
tization, internalization, and signaling of human and Xenopus
GnRH-Rs using recombinant adenovirus to express these re-
ceptors in HeLa cells expressing either wild-type or K44A
(dominant negative) dynamin. GnRH-Rs expressed in this way
had high affinity for receptor-specific ligands (low nM Kd for
125I-buserelin binding to hGnRH-Rs and for 125I-cGnRH-II
binding to XGnRH-Rs) and mediate PLC activation, Ca2 mo-
bilization, and MAP kinase (ERK 2) activation. They also show
different ligand specificity (buserelinGnRHcGnRH-II at
hGnRH-Rs and cGnRH-IIbuserelinGnRH at XGnRH-Rs)
and different rates of internalization and desensitization (both
being more rapid for the XGnRH-R). Receptor density, and
receptor-mediated effects on [3H]IP accumulation and [Ca2]i
were all increased by increasing viral titer from m.o.i. values of
3–100, and Ca2 imaging experiments revealed that 90%
of the cells were GnRH-responsive after infection at an m.o.i. of
10. Accordingly, the increases in hGnRH-R number caused by
increasing m.o.i. from 10 to 100 (14,600–46,500 receptors/cell)
reflects an increase in receptors/cell rather than in the propor-
tion of cells expressing the receptor. These values compare well
to the range of densities of endogenous mammalian GnRH-Rs
in pituitary gonadotrophs (33). Thus, recombinant Ad provide
an efficient means of expressing GnRH-Rs in HeLa cells at
physiological density, and these receptors retain the pharma-
cological characteristics anticipated from earlier studies with
endogenous GnRH-Rs and GnRH-Rs expressed heterologously
in pituitary gonadotrope progenitor cells (26, 34, 35).
The dynamin dependence of EGF receptor internalization
has previously been demonstrated in K44A dynamin cells (3)
and was confirmed here as a positive control for blockade of
dynamin-dependent endocytosis. Using this system, we have
found, as expected, that internalization of the XGnRH-R is
more rapid than that of the hGnRH-R in K44A dynamin cells
cultured with tetracycline. Blockade of dynamin-dependent in-
ternalization by tetracycline omission did not reduce hGnRH-R
internalization. This was unexpected because transient expres-
sion of K44A dynamin has been reported to inhibit internaliza-
tion of the rat GnRH-R by 20% in COS 7 cells (32). Although a
tendency for inhibition was observed at the 60- and 120-min
time points (Fig. 3), and in some subsequent experiments (e.g.
Fig. 4), this did not attain statistical significance (even when
data were pooled from multiple series of experiments), and we
were therefore unable to demonstrate any measurable dy-
namin dependence of hGnRH-R internalization in HeLa cells.
In stark contrast, the internalization of XGnRH-Rs was dra-
matically reduced when dynamin-dependent internalization
was prevented by tetracycline omission.
Internalization of several GPCRs is inhibited by expression
of dominant negative mutants of dynamin (6, 15) and by pre-
vention of CCV formation using hypertonic sucrose (31). Al-
though these treatments are not entirely specific for CCVs (4,
11, 37, 38), electron microscopy has revealed that mammalian
GnRH-R are internalized via coated vesicles (39) and co-inter-
nalization with transferrin (a marker for CCV-mediated inter-
nalization) implies that these are CCVs (25). We have recently
found that the XGnRH-R also co-internalizes with transferrin
(not shown). Accordingly, the sucrose-dependent internaliza-
tion of both GnRH-R in HeLa cells is also most likely
CCV-mediated.
We were concerned that the observed differences in GnRH-R
internalization might reflect differences in receptor number
and tested this by expressing receptors at varied density (vary-
ing viral titer between m.o.i. values of 3–100). This revealed a
negative correlation between XGnRH-R binding and internal-
ization rate (Fig. 3), supporting the notion that the stoichiom-
etry of receptors and other proteins can indeed influence the
observed internalization. However, the key distinctions be-
tween hGnRH-R and XGnRH-R internalization (faster inter-
nalization and dynamin sensitivity of the later) are maintained
over a wide range of receptor density (Fig. 4). The retention of
these distinctions with a range of XGnRH-Rs estimated to
encompass that of the hGnRH-Rs clearly demonstrates depend-
ence on receptor structure rather than receptor density.
The best-explored pathway for ERK 2 activation by tyrosine
kinase receptors involves Shc/Grb2-mediated activation of a
Ras guanine nucleotide exchange factor that activates the mo-
nomeric G-protein, Ras. This in turn activates Raf, which phos-
phorylates MEK causing it to phosphorylate ERK 2. Numerous
GPCRs, including GnRH-Rs, have also been shown to activate
ERK 2 by feeding into this pathway at multiple sites (41, 42).
Up-stream activation can be achieved by GPCR-mediated
transactivation of EGF receptor involving stimulated libera-
tion of HB-EGF in the extracellular environment (19). For
Gq-coupled GPCRs activation of PKC can lead to Raf activa-
tion, and Ca2 elevation can activate a Ras G-protein regula-
tory factor. More recently, -arrestin, recruited to 2-adrener-
gic receptors, was shown to bind Src, which can regulate Shc/
GRb2 (12, 36, 43), and the observation that dominant negative
mutants of -arrestin or dynamin-blocked ERK 2 activation
implied that GPCR endocytosis was necessary for signaling to
the MAP kinase. These observations are intriguing, not only
FIG. 9. Tyrosine kinase dependence of GnRH-R-mediated acti-
vation of ERK 2 in K44A dynamin cells infected with Ad
hGnRH-R or Ad XGnRH-R. K44A dynamin cells were infected with
Ad hGnRH-R or Ad XGnRH-R at m.o.i. values of 50–100 before being
cultured with tetracycline. Cells were then pretreated with PSS with or
without 1000 nM AG1478 for 30 min before being stimulated with PSS
containing 107 M GnRH (hGnRH-R) or cGnRH-II (XGnRH-R) or 107
M EGF (EGF-R) for 10 min before extraction. Data is expressed as the
percentage of ERK 2 that is in the phosphorylated form from pooled
observations (n  3) as determined by densitometry measurement. *
p  0.05 compared with maximal stimulation (no inhibitor).


























because they demonstrate signaling of the “desensitized” recep-
tor, but also because Src phosphorylates and activates dynamin
(44), providing a mechanism for activation of dynamin-depend-
ent internalization by the GPCR. However, EGF receptor sig-
naling and MEK signaling are also dynamin-dependent (3, 16),
so the dynamin dependence of GPCR signaling can actually
reflect the fact that GPCR activation impinges on the EGF
receptor/ERK 2 signaling pathway (reviewed in Ref. 42).
From these observations, it is clear that understanding the
relationship between GPCR cycling and ERK 2 activation will
depend upon the loci at which the GPCR signaling pathway
feeds into the MAP kinase cascade. Here, we have found that
hGnRH-R and XGnRH-R both mediate ERK 2 phosphorylation
(indicative of activation of the ERK 1/2 signaling cassette) in
K44A cells cultured with tetracycline. To our knowledge, this is
the first demonstration of MAP kinase activation by a non-
mammalian GnRH-R, and it is therefore of interest that time-
courses and amplitudes of the responses were indistinguish-
able. This clearly implies that rapid GPCR desensitization
(seen for the XGnRH-R but not for the hGnRH-R) is not an
important determinant of the kinetics of this response. It re-
mains to be determined whether -arrestin-mediated signaling
(which may occur for the XGnRH-R but presumably not for the
hGnRH-R) supports the response to XGnRH-R activation.
In addressing the mechanisms of ERK 2 activation we found
that the tyrphostin AG 1478 abolished EGF-stimulated ERK 2
activation at a concentration that does not inhibit the response
to activation of either of the GnRH-Rs used. ERK activation by
the endogenous mouse GnRH-R of T3–1 pituitary cells has
also been shown to be resistant to inhibition by AG1478 and by
dominant negative EGF receptors (40) despite the fact that
earlier work had implied a role for EGF receptor transactiva-
tion in GnRH action (18). In the HeLa cells used here, the
differential sensitivity to AG1478 clearly implies that EGF-R
activation (17–19)) does not underlie GnRH-R-mediated ERK 2
activation. However, we have also found that activation of ERK
2 by both GnRH-Rs was partially inhibited by dynamin despite
the fact that internalization of the hGnRH-R was not. This
uncoupling clearly argues that dynamin-dependent internal-
ization of the GPCR is not required for dynamin-dependent
ERK 2 activation.
The interpretation above is reinforced by the fact that inhibi-
tion of XGnRH-R internalization with concanavalin A did not
reduce XGnRH-R-mediated ERK 2 activation. Moreover, we
found that PMA-stimulated ERK 2 activation is also dynamin-
dependent and that the PKC inhibitor (bisindolylmaleimide 1)
inhibited ERK 2 activation by both GnRH-Rs. Although multiple
mechanisms are likely to be involved, the simplest interpretation
of these data is that GnRH-R-mediated ERK 2 activation is
largely PKC-mediated in these cells and that it is dynamin-de-
pendent because signaling from PKC to ERK 2 is, at least in part,
dynamin-dependent. Recent studies in pituitary cells indicate
that GnRH activates ERK primarily by causing a PKC-mediated
activation of Raf with only a minor contribution from Src and Ras
to Raf activation (40). GnRH-stimulated ERK activation was also
found to be partially dynamin-sensitive in this system, but this
effect was confined to inhibition of the Src/Ras signaling step (e.g.
up-stream of, or unrelated to, PKC activation). However, this
does not hold true in HeLa cells where events downstream of
PKC are also dynamin-dependent (e.g. PMA-stimulated ERK 2
activation is inhibited by K44A dynamin). Signaling by MEK,
which lies down-stream of PKC in the GnRH-R signaling cas-
cade, has been shown to be dynamin-dependent in COS 7 cells
(16). In this system, the dynamin-dependent endocytosis of acti-
vated MEK was critical for MAPK activation, and this relation-
ship may well explain the dynamin dependence of GnRH-R sig-
naling shown here.
In the preceding sections, inhibition by K44A dynamin has
been equated with “dynamin dependence”, but this may be an
over-simplification because internalization of different GPCRs
has been found to be differentially sensitive to distinct mutants
of dynamin (11). This raises the possibility that the K44A
dynamin-independent hGnRH-R internalization described
here might prove sensitive to other dynamin mutants, but even
if this is the case, the difference between the hGnRH-R and the
XGnRH-R (and EGF receptor) in terms of sensitivity to K44A
dynamin 1 implies that they access functionally distinct inter-
nalization routes.
In summary, a functional comparison of human and Xenopus
GnRH-Rs has revealed that the tail-less mammalian GnRH-R
internalizes and desensitizes slowly as compared with a tailed
non-mammalian GnRH-R, and that this distinction is a func-
tion of receptor type rather than receptor density. Expression
of K44A dynamin did not measurably alter desensitization or
hGnRH-R internalization but dramatically reduced internal-
ization of the XGnRH-R and EGF receptor, whereas blockade of
CCV formation with sucrose abolished internalization of all
three receptors. The tyrphostin, AG 1478, blocked EGF-stimu-
lated, but not GnRH-R-mediated, ERK 2 activation, demon-
strating that EGF receptor transactivation is not mediating
GnRH action in these cells. K44A dynamin expression also
inhibited ERK 2 activation mediated by either GnRH-R,
whereas inhibition of GnRH-R internalization with concanava-
lin A did not influence GnRH-R-mediated ERK 2 activation.
PMA also caused a dynamin-dependent activation ERK 2, and
the effects of PMA, GnRH, and cGnRH-II on ERK 2 phospho-
rylation were all blocked by a PKC inhibitor. Thus we have
established that a) desensitizing and non-desensitizing
GnRH-Rs are targeted for CCV-mediated internalization by
functionally distinct mechanisms, b) GnRH-R signaling to ERK
2 is dynamin-dependent, and c) this does not reflect a depend-
ence on dynamin-regulated GnRH-R internalization but may
instead be attributable to the dynamin dependence of PKC-
mediated MEK activation.
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